Presentation is loading. Please wait.

Presentation is loading. Please wait.

18F-Sodium Fluoride PET–CT for the Assessment of Brain Metastasis from Lung Adenocarcinoma  Stefania Gori, MD, Alessandro Inno, MD, PhD, Gianluigi Lunardi,

Published byMarianna Garrett Modified over 6 years ago

Similar presentations

Presentation on theme: "18F-Sodium Fluoride PET–CT for the Assessment of Brain Metastasis from Lung Adenocarcinoma  Stefania Gori, MD, Alessandro Inno, MD, PhD, Gianluigi Lunardi,"— Presentation transcript:

1 18F-Sodium Fluoride PET–CT for the Assessment of Brain Metastasis from Lung Adenocarcinoma 
Stefania Gori, MD, Alessandro Inno, MD, PhD, Gianluigi Lunardi, PharmD, Giancarlo Gorgoni, PharmD, Veronica Malfatti, MD, Fabrizia Severi, ScD, Filippo Alongi, MD, Giovanni Carbognin, MD, Luigi Romano, MD, Stefano Pasetto, ScD, Matteo Salgarello, MD, PhD  Journal of Thoracic Oncology  Volume 10, Issue 8, Pages e67-e68 (August 2015) DOI: /JTO Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Imaging of brain metastasis before starting systemic therapy. A, Brain MRI showing 12 mm right parietal metastasis with surrounding edema. B, 18F-NaF PET-CT with right parietal brain metastasis uptake 5 minutes after tracer injection; at that time, 18F-NaF is also detectable in the bloodstream within dural venous sinuses. C, 18F-NaF PET-CT 30 minutes after tracer injection; at that time, 18F-NaF is mainly uptaken by cranial bones, but residual uptake of brain metastasis is still detectable. MRI, magnetic resonance imaging; NaF, sodium fluoride; PET–CT, positron emission tomography–computed tomography. Journal of Thoracic Oncology  , e67-e68DOI: ( /JTO ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Imaging of brain metastasis after two cycles of cisplatin and pemetrexed. A, Brain MRI showing right parietal metastasis, decreased in size when compared with baseline (9 vs 12 mm, see Fig. 1). B, 18F-NaF PET-CT performed 5 minutes after tracer injection; the uptake intensity of brain metastasis has decreased from baseline: SUVmax from 4.20 to 2.40 (see Fig. 1). C, 18F-NaF PET-CT 30 minutes after tracer injection. MRI, magnetic resonance imaging; NaF, sodium fluoride; PET–CT, positron emission tomography–computed tomography. Journal of Thoracic Oncology  , e67-e68DOI: ( /JTO ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "18F-Sodium Fluoride PET–CT for the Assessment of Brain Metastasis from Lung Adenocarcinoma  Stefania Gori, MD, Alessandro Inno, MD, PhD, Gianluigi Lunardi,"

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.

Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.
Intramedullary Spinal Cord Hemorrhage after Treatment with Bevacizumab in a Long- term Survivor with Metastatic Non–Small-Cell Lung Cancer  Kristin N.

Intramedullary Spinal Cord Hemorrhage after Treatment with Bevacizumab in a Long- term Survivor with Metastatic Non–Small-Cell Lung Cancer  Kristin N.
Gingival Metastasis as First Sign of Multiorgan Dissemination of Epithelioid Malignant Mesothelioma  Andrea Billè, Marco Platania, Giuseppe Pelosi, Barbara.

Gingival Metastasis as First Sign of Multiorgan Dissemination of Epithelioid Malignant Mesothelioma  Andrea Billè, Marco Platania, Giuseppe Pelosi, Barbara.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients 

A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients 
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful.

Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful.
Paraneoplastic Limbic Encephalitis and Small-Cell Lung Carcinoma

Paraneoplastic Limbic Encephalitis and Small-Cell Lung Carcinoma
Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR  Eamon M. Berge, MD, Dara L. Aisner, MD, PhD, Robert C. Doebele,

Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR  Eamon M. Berge, MD, Dara L. Aisner, MD, PhD, Robert C. Doebele,
MET-Mutated NSCLC with Major Response to Crizotinib

MET-Mutated NSCLC with Major Response to Crizotinib
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M–Mutant Leptomeningeal Lung Adenocarcinoma  Christine Cordova, MD, Andrew S. Chi,

Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M–Mutant Leptomeningeal Lung Adenocarcinoma  Christine Cordova, MD, Andrew S. Chi,
Long-Lasting Response to Nivolumab and Immune-Related Adverse Events in a Nonsquamous Metastatic Non–Small Cell Lung Cancer Patient  Biagio Ricciuti,

Long-Lasting Response to Nivolumab and Immune-Related Adverse Events in a Nonsquamous Metastatic Non–Small Cell Lung Cancer Patient  Biagio Ricciuti,
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non– Small-Cell Lung Cancer  Josette Biya, MD, Caroline Caramella, MD, Colin.

A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non– Small-Cell Lung Cancer  Josette Biya, MD, Caroline Caramella, MD, Colin.
Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation.

Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation.

Similar presentations

Ads by Google